Furthermore, there was a significant reduction in the levels of the proinflammatory cytokine IL-6 in both the plasma (Figure 4A) and PBMCS (Figure 4B) from T2DM subjects who received L-GSH supplement. The gene discussed is IL6; the disease is type 2 diabetes mellitus.